关注
Chris Miller
Chris Miller
在 wustl.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
Cancer Genome Atlas Research Network Tissue source sites: Duke University ...
Nature 455 (7216), 1061-1068, 2008
74322008
VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing
DC Koboldt, Q Zhang, DE Larson, D Shen, MD McLellan, L Lin, CA Miller, ...
Genome Research 22 (3), 568-576, 2012
48862012
Mutational landscape and significance across 12 major cancer types
C Kandoth, MD McLellan, F Vandin, K Ye, B Niu, C Lu, M Xie, Q Zhang, ...
Nature 502 (7471), 333-339, 2013
47542013
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
TCGAR Network
New England Journal of Medicine 368 (22), 2059-2074, 2013
4740*2013
Comprehensive molecular profiling of lung adenocarcinoma
Cancer Genome Atlas Research Network
Nature 511 (7511), 543, 2014
39002014
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
L Ding, TJ Ley, DE Larson, CA Miller, DC Koboldt, JS Welch, JK Ritchey, ...
Nature, 2012
25332012
Age-related mutations associated with clonal hematopoietic expansion and malignancies
M Xie, C Lu, J Wang, MD McLellan, KJ Johnson, MC Wendl, ...
Nature medicine 20 (12), 1472-1478, 2014
19312014
The Origin and Evolution of Mutations in Acute Myeloid Leukemia
JS Welch, TJ Ley, DC Link, CA Miller, DE Larson, DC Koboldt, ...
Cell 150 (2), 264-278, 2012
18352012
Whole-genome analysis informs breast cancer response to aromatase inhibition
MJ Ellis, L Ding, D Shen, J Luo, VJ Suman, JW Wallis, BA Van Tine, ...
Nature 486 (7403), 353-360, 2012
12072012
Comprehensive and integrated genomic characterization of adult soft tissue sarcomas
AJ Lazar, MD McLellan, MH Bailey, CA Miller, EL Appelbaum, MG Cordes, ...
Cell 171 (4), 950-965, 2017
8322017
Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia
TN Wong, G Ramsingh, AL Young, CA Miller, W Touma, JS Welch, ...
Nature 518 (7540), 552-555, 2015
8282015
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
JS Welch, AA Petti, CA Miller, CC Fronick, M O’Laughlin, RS Fulton, ...
New England Journal of Medicine 375 (21), 2023-2036, 2016
8262016
Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts
S Li, D Shen, J Shao, R Crowder, W Liu, A Prat, X He, S Liu, J Hoog, C Lu, ...
Cell reports 4 (6), 1116-1130, 2013
6972013
DGIdb: mining the druggable genome
M Griffith, OL Griffith, AC Coffman, JV Weible, JF McMichael, NC Spies, ...
Nature methods 10 (12), 1209-1210, 2013
5112013
SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution
CA Miller, BS White, ND Dees, M Griffith, JS Welch, OL Griffith, R Vij, ...
PLoS computational biology 10 (8), e1003665, 2014
4922014
The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramers
DA Russler-Germain, DH Spencer, MA Young, TL Lamprecht, CA Miller, ...
Cancer cell 25 (4), 442-454, 2014
4722014
Functional heterogeneity of genetically defined subclones in acute myeloid leukemia
JM Klco, DH Spencer, CA Miller, M Griffith, TL Lamprecht, M O’Laughlin, ...
Cancer cell 25 (3), 379-392, 2014
4322014
Immune escape of relapsed AML cells after allogeneic transplantation
MJ Christopher, AA Petti, MP Rettig, CA Miller, E Chendamarai, ...
New England Journal of Medicine 379 (24), 2330-2341, 2018
4002018
Association between mutation clearance after induction therapy and outcomes in acute myeloid leukemia
JM Klco, CA Miller, M Griffith, A Petti, DH Spencer, S Ketkar-Kulkarni, ...
Jama 314 (8), 811-822, 2015
3832015
Key parameters of tumor epitope immunogenicity revealed through a consortium approach improve neoantigen prediction
DK Wells, MM van Buuren, KK Dang, VM Hubbard-Lucey, KCF Sheehan, ...
Cell 183 (3), 818-834. e13, 2020
3592020
系统目前无法执行此操作,请稍后再试。
文章 1–20